Founded in 1986 by two former managers at Abbott Laboratories, France, Biomedical Diagnostics was initially an in vitro diagnostics distribution company specialising in autoimmune disease assays.
1990: the company started to expand with complementary R&D and Production activities and its range was extended to include allergy and infectious disease detection tests.
From the early 1990s, BMD became the leader on the French autoimmune disease diagnostic market.
October 1999: BMD signed a partnership agreement with the Luminex Corporation, US who developed the Xmap (multiplex) technology. BMD was the only French company to have signed an agreement with Luminex at this time and very rapidly started to develop and produce multiplex diagnostic kits.
The year 2000 marked a new stage in the expansion of the international distribution network with the creation of a dedicated export department and an increase in partnership agreements with new distributors.
BMD's determination to enter innovative markets and its abilities to expand rapidly have meant that it has acquired the confidence of venture capitalists. A first pool, conducted in 2000, will be followed by other fundraising rounds.
As of now, our aim is to position ourselves as the leading French distributor of IVD products, BMD is now the leader on the French auto-immunity market (25% of market share) and is establishing itself as a major European player in the development and production of kits based on Multiplex technology.
